M. Bryant, Christopher L. Albertus, Daniel Kim, Sinae Chen, Guoan Brambilla, Christian Guedj, Mickael Arima, Chinatsu D. Travis, William Yatabe, Yasushi Takahashi, Takashi Brambilla, Elisabeth G. Beer, David Clusters and Pathways. <p>Tumors with lower levels of the cell cycle stimulatory (CC+) were more likely to be in Cluster 1 or 2, other pathways held constant. Tumors with higher levels of the IGF-1 pathway were more likely to be in Cluster 2 and less likely to be in Cluster 1. Samples with increased antigen pathway expression were more likely to be in Cluster 2 and less likely to be in Cluster 3. Tumors with increased complement pathway expression were more likely to be in Cluster 1 and less likely to be in Cluster 3. NA indicates that the variable was excluded during model selection and thus deemed unimportant.</p> genetics and genomics/gene expression;molecular biology/bioinformatics;oncology/lung cancer;pathology/surgical pathology 2010-07-22
    https://plos.figshare.com/articles/dataset/_Clusters_and_Pathways_/511413
10.1371/journal.pone.0011712.t003